Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Always Active
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.

No cookies to display.

Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.

No cookies to display.

 

Microspheres with high drug loading suitable for taste masking, enteric coatings, and extended release oral applications

Optimμm® technology overcomes many of the inefficiencies and deficits of traditional techniques. Optimμm® offers a wide range of modified release options using flexible format powders. It can match an extended release tablet’s performance in a suspension format. And with Optimμm® you don’t have to sacrifice taste to achieve a dispersed solid oral dosage form.

 

Optimμm® delivers on the promise of precision microparticles at a previously unachievable scale

  • Particle sizes down to 75 μm with Span values as low as 0.40
  • Uses a nitrogen “carrier” stream
  • Analogous to spray congealing
  • No drying step or coating required
  • Compatible with waxes, lipids, stearates, and gelatins
  • Good for oral small molecules, nutraceuticals, agricultural applications, flavorings, and heat stable molecules

Speak With An Expert

Profile Photo: Nathan Dormer

Nathan Dormer

Director, Drug Product Development

Nathan Dormer, Ph.D., is the Director of Drug Product Development at Adare Pharma Solutions and is responsible for pharmaceutical development activities at Adare’s Lenexa, KS and Philadelphia, PA facilities, where he supports a team of formulation scientists and analysts. He is a pharmaceutical scientist and bioengineer by training, with more than 16 years of experience developing microsphere-based solid oral and parenteral/implantable dosage forms in academic, innovator, and CDMO settings. Dr. Dormer earned his B.S. in Chemical Engineering and his Ph.D. (w/Honors) in Bioengineering from The University of Kansas while receiving NIH-sponsored Pharmaceutical Biotech Training.

Contact Me

What question can I answer for you?

"*" indicates required fields

Personal details

Company

Let us know how we can help

0 of 1000 max characters
By ticking this box, you acknowledge and agree to our GDPR compliance and privacy policy*
opt-in for SMS marketing
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form
This field is hidden when viewing the form